drugset / Trial / NCT02422888

Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor

NCT02422888 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The current trial will compare the protective effect of ticagrelor and prasugrel on microvascular dysfunction in patients with revascularized ST elevation myocardial infarction.

Timeline

Start
2015-05
Primary completion
2017-10
Completion
2019-10

Outcome

Missed primary endpoint

paper The primary outcome of index of microcirculatory resistance was not superior PMID 30586720 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prasugrel Small molecule 10 mg —
Subject Ticagrelor Small molecule 90 mg —

Indications